The prevalence of victims of Thalidomide is difficult to determine with absolute certainty due to various factors such as unreported cases and the passage of time. However, it is estimated that thousands of individuals worldwide were affected by Thalidomide during the late 1950s and early 1960s. The drug, prescribed to pregnant women to alleviate morning sickness, caused severe birth defects in their babies. These victims experienced limb abnormalities, organ malformations, and other disabilities. The tragedy led to increased awareness of drug safety and stricter regulations in the pharmaceutical industry.
The prevalence of victims of Thalidomide is a tragic and significant issue that has had a lasting impact on individuals and families around the world. Thalidomide was a medication prescribed to pregnant women in the late 1950s and early 1960s to alleviate morning sickness. However, it was later discovered that the drug caused severe birth defects, particularly affecting the development of limbs.
Exact figures on the prevalence of Thalidomide victims vary, but it is estimated that around 10,000 to 20,000 children worldwide were affected by the drug. These children, often referred to as "Thalidomide babies," faced significant physical challenges and disabilities throughout their lives.
The impact of Thalidomide led to widespread awareness of the need for stricter drug testing and regulations, resulting in significant changes in pharmaceutical safety protocols. The tragedy also sparked a global movement advocating for the rights and support of individuals affected by Thalidomide.
Today, many Thalidomide victims continue to face daily challenges, but their resilience and determination have inspired advancements in medical care, accessibility, and support systems for people with disabilities.